Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_42815 | 109 | 2.26 | Mlig455_021685 | Neo: - Age: - Region-enriched R7: 3.999/0.00913 |
Mlig455_021685 {REF} {Length: 1923} {RNA1310_28094} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.792 | 1.745 | 0.62656 | 1.00000 | |
RegionR2 | 1.281 | 1.745 | 0.38318 | 0.77817 | |
RegionR3 | -1.499 | 1.745 | 0.99677 | 1.00000 | |
RegionR4 | -0.891 | 1.745 | 0.98811 | 1.00000 | |
RegionR5 | -0.901 | 1.745 | 0.98537 | 1.00000 | |
RegionR6 | -0.787 | 1.745 | 0.97871 | 1.00000 | |
RegionR7 | 3.999 | 1.745 | 0.00018 | 0.00913 | |
RegionR8 | 1.59 | 1.745 | 0.34017 | 0.97393 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.956 | 1.745 | 0.99984 | 1.00000 | |
RegenerationR2 | -0.543 | 1.745 | 0.61213 | 0.92012 | |
RegenerationR3 | 1.21 | 1.745 | 0.38021 | 0.79061 | |
RegenerationR4 | 0.821 | 1.745 | 0.52992 | 0.88417 | |
RegenerationR5 | -0.806 | 1.745 | 0.55757 | 0.88981 | |
RegenerationR6 | -0.451 | 1.745 | 0.74784 | 0.95107 | |
RegenerationBL | -0.646 | 1.745 | 0.68622 | 1.00000 | |
RegenerationTP | -0.629 | 1.745 | 0.64239 | 0.98464 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_42815 | 109 | 2.26 | Mlig455_021685 | Neo: - Age: - Region-enriched R7: 3.999/0.00913 |
4 | 1.000 | - | 1.000 | - | 1.000 | 1.000 | Mlig455_021685 {REF} {Length: 1923} {RNA1310_28094} | |
2. | MligTC455_15755 | 62 | 1.3 | Mlig455_051284 | Neo: - Age: - Region-enriched R7: 4.959/0.00065 |
CHRNB3 | 1.857 | 0.965 | - | - | - | - | 0.892 | Mlig455_051284 {REF} {Length: 2666} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=130.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=32.4]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=142, Expect=1e-37]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=139, Expect=2e-36]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=137, Expect=1e-35]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=160, Expect=5e-44]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=146, Expect=9e-39]} {Celegans: WBGene00020048, lgc-12, Ligand-Gated ion Channel, [Score=140, Expect=2e-37]} {Smed: dd_Smed_v6_29533_0_1, dd_Smed_v6_29533_0_1, [RH, Score=205, Expect=1e-61]} {RNA1310_22037} {RNA815_37244} |
3. | MligTC455_51024 | 78 | 1.63 | Mlig455_042673 | Neo: - Age: - Region-enriched R8: 6.900/0.00001 |
1.801 | 0.962 | - | - | - | - | 0.839 | Mlig455_042673 {REF} {Length: 1953} {RNA1310_20305} {RNA815_32236} | |
4. | MligTC455_15986 | 139 | 2.9 | Mlig455_048132 | Neo: - Age: - Region-enriched R8: 5.016/0.00239 |
1.783 | 0.954 | - | - | - | - | 0.829 | Mlig455_048132 {REF} {Length: 1543} {RNA1509_47436} {RNA1310_22809.1} {RNA815_55300} | |
5. | MligTC455_08906 | 71 | 1.47 | Mlig455_013161 | Neo: - Age: - |
1.745 | 0.955 | - | - | - | - | 0.790 | Mlig455_013161 {REF} {Length: 694} | |
6. | MligTC455_09240 | 297 | 6.19 | Mlig455_023411 | Neo: - Age: Down-Up-Down Region-enriched R7: 5.816/0.00000 |
1.71 | 0.960 | - | - | - | - | 0.750 | Mlig455_023411 {REF} {Length: 2218} {RNA1509_41055} {RNA1310_11481.1} {RNA815_19026} | |
7. | MligTC455_07668 | 37 | 0.78 | Mlig455_051218 | Neo: - Age: - |
LRG1 | 1.705 | 0.967 | - | - | - | - | 0.738 | Mlig455_051218 {REF} {Length: 1983} {Pfam: Leucine rich repeat [PF13855.8, score=58.7]; Leucine Rich repeats (2 copies) [PF12799.9, score=35.9]; Leucine Rich Repeat [PF00560.35, score=20.3]} {Human: ENSG00000171236, LRG1, leucine rich alpha-2-glycoprotein 1, [Score=62.8, Expect=3e-10]} {Mouse: ENSMUSG00000037095, Lrg1, leucine-rich alpha-2-glycoprotein 1, [Score=56.6, Expect=2e-08]; ENSMUSG00000052316, Lrrc15, leucine rich repeat containing 15, [Score=53.9, Expect=2e-07]} {Dmel: FBgn0262473, Tl, Toll, [Score=57.4, Expect=2e-08]} {Celegans: WBGene00006593, tol-1, TOLl (Drosophila) family, [Score=60.1, Expect=2e-09]} {RNA1310_98686} |
8. | MligTC455_53118 | 133 | 2.76 | Mlig455_029477 | Neo: - Age: - |
CHRNA2 | 1.665 | 0.961 | - | 0.704 | - | - | - | Mlig455_029477 {REF} {Length: 3006} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=160.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.2]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=212, Expect=1e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=210, Expect=4e-59]} {Mouse: ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=209, Expect=3e-59]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=207, Expect=2e-59]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=204, Expect=1e-58]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=204, Expect=4e-58]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=208, Expect=1e-57]} {Celegans: WBGene00043066, acr-25, AcetylCholine Receptor, [Score=202, Expect=2e-57]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=437, Expect=6e-147]} {RNA1509_18288} {RNA1310_21192} {RNA815_24334} |
9. | MligTC455_15927 | 157 | 3.26 | Mlig455_032763 | Neo: - Age: logFC(26M/2M)=1.700 |
0.98 | - | - | - | - | - | 0.980 | Mlig455_032763 {REF} {Length: 628} {RNA1509_55349} {RNA1310_76770, RNA1509_55349} {RNA1509_55349, RNA815_39882} | |
10. | MligTC455_39396 | 469 | 9.77 | Mlig455_031203 | Neo: - Age: - Region-enriched R8: 3.069/0.00001 |
ARRDC3 | 0.97 | - | - | - | - | - | 0.970 | Mlig455_031203 {REF} {Length: 1835} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=114.8]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=66.5]; Rgp1 [PF08737.12, score=23.6]} {Human: ENSG00000113369, ARRDC3, arrestin domain containing 3, [Score=112, Expect=5e-27]} {Mouse: ENSMUSG00000074794, Arrdc3, arrestin domain containing 3, [Score=113, Expect=1e-27]} {Dmel: FBgn0037517, CG10086, [RH, Score=85.1, Expect=1e-17]} {Celegans: WBGene00009579, arrd-6, ARRestin Domain protein, [RH, Score=322, Expect=2e-106]} {RNA1509_30037} {RNA1310_19411, RNA1509_30037} {RNA1509_30037, RNA815_7851} |
11. | MligTC455_07669 | 60 | 1.26 | Mlig455_063001 | Neo: - Age: - |
LRG1 | 0.969 | 0.969 | - | - | - | - | - | Mlig455_063001 {REF} {Length: 2041} {Pfam: Leucine rich repeat [PF13855.8, score=55.4]; Leucine Rich repeats (2 copies) [PF12799.9, score=33.0]} {Human: ENSG00000171236, LRG1, leucine rich alpha-2-glycoprotein 1, [Score=62.0, Expect=6e-10]; ENSG00000040608, RTN4R, reticulon 4 receptor, [Score=58.9, Expect=1e-08]} {Mouse: ENSMUSG00000052316, Lrrc15, leucine rich repeat containing 15, [Score=52.8, Expect=5e-07]; ENSMUSG00000043496, Tril, TLR4 interactor with leucine-rich repeats, [Score=52.0, Expect=1e-06]} {Dmel: FBgn0262473, Tl, Toll, [Score=57.0, Expect=3e-08]} {Celegans: WBGene00006593, tol-1, TOLl (Drosophila) family, [Score=59.3, Expect=3e-09]} {RNA1310_98686} |
12. | MligTC455_22298 | 53 | 1.11 | Mlig455_049908 | Neo: - Age: - Region-enriched R7: 3.516/0.03382 |
0.968 | 0.968 | - | - | - | - | - | Mlig455_049908 {REF} {Length: 2118} {NoTransDecoderORF} {RNA1509_26115} {RNA1310_129689} {RNA815_9283.1} | |
13. | MligTC455_53707 | 903 | 18.82 | Mlig455_001231 | Neo: - Age: Down-Up-Up Region-specific R2: 3.242 Region-enriched R2: 1.917/0.00133 Regeneration-downregulated BL: -2.295 Regeneration-depleted BL: -2.295 |
0.966 | - | - | - | - | - | 0.966 | Mlig455_001231 {REF} {Length: 737} {RNA1509_13584, RNA1509_53181, RNA1509_55651} {RNA1310_60643.1, RNA1509_13584, RNA1509_53181, RNA1509_55651} {RNA1509_13584, RNA1509_53181, RNA1509_55651, RNA815_32307.1} | |
14. | MligTC455_48961 | 234 | 4.87 | Mlig455_014097, Mlig455_014109 | Neo: - Age: - |
0.965 | - | - | - | - | - | 0.965 | Mlig455_014097 {REF} {Length: 2212} {Pfam: PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=26.7]; PMP-22/EMP/MP20/Claudin family [PF00822.22, score=20.9]} {Dmel: FBgn0034267, CG4984, [RH, Score=69.7, Expect=7e-13]} {Smed: dd_Smed_v6_9946_0_1, dd_Smed_v6_9946_0_1, [RH, Score=56.2, Expect=5e-09]} {RNA1509_43217} {RNA1310_16701, RNA1509_43217} {RNA1509_43217, RNA815_8110} Mlig455_014109 {REF} {Length: 1797} {RNA1509_43217} {RNA1310_42656} {RNA815_8110} |
|
15. | MligTC455_20838 | 235 | 4.89 | Mlig455_022987 | Neo: - Age: - |
H6PD | 0.964 | - | - | - | - | - | 0.964 | Mlig455_022987 {REF} {Length: 2684} {TRANSSPLICED} {Pfam: Glucosamine-6-phosphate isomerases/6-phosphogluconolactonase [PF01182.22, score=105.1]; Glucose-6-phosphate dehydrogenase, C-terminal domain [PF02781.18, score=96.2]; Glucose-6-phosphate dehydrogenase, NAD binding domain [PF00479.24, score=82.3]} {Human: ENSG00000049239, H6PD, hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, [Score=210, Expect=1e-56]} {Mouse: ENSMUSG00000028980, H6pd, hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase), [Score=222, Expect=5e-61]} {Dmel: FBgn0004057, Zw, Zwischenferment, [Score=142, Expect=3e-35]} {Celegans: WBGene00007108, gspd-1, Glucose-6-phosphate 1-dehydrogenase, [Score=133, Expect=1e-32]} {Smed: dd_Smed_v6_2965_0_1, dd_Smed_v6_2965_0_1, [Score=132, Expect=2e-32]} {RNA1509_16416} {RNA1310_9105, RNA1509_16416} {RNA1509_16416, RNA815_2264.1} |
16. | MligTC455_40069 | 29 | 0.6 | Mlig455_069962 | Neo: - Age: - |
CHRM4 | 0.959 | 0.959 | - | - | - | - | - | Mlig455_069962 {REF} {Length: 3350} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=235.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=71.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=33.4]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=24.0]} {Human: ENSG00000180720, CHRM4, cholinergic receptor muscarinic 4, [Score=151, Expect=1e-38]; ENSG00000168539, CHRM1, cholinergic receptor muscarinic 1, [Score=151, Expect=8e-39]; ENSG00000184984, CHRM5, cholinergic receptor muscarinic 5, [Score=150, Expect=7e-38]; ENSG00000181072, CHRM2, cholinergic receptor muscarinic 2, [Score=147, Expect=2e-37]; ENSG00000133019, CHRM3, cholinergic receptor muscarinic 3, [Score=147, Expect=1e-36]} {Mouse: ENSMUSG00000032773, Chrm1, cholinergic receptor, muscarinic 1, CNS, [Score=152, Expect=5e-39]; ENSMUSG00000040495, Chrm4, cholinergic receptor, muscarinic 4, [Score=152, Expect=5e-39]; ENSMUSG00000045613, Chrm2, cholinergic receptor, muscarinic 2, cardiac, [Score=149, Expect=4e-38]; ENSMUSG00000074939, Chrm5, cholinergic receptor, muscarinic 5, [Score=149, Expect=2e-37]; ENSMUSG00000046159, Chrm3, cholinergic receptor, muscarinic 3, cardiac, [Score=147, Expect=8e-37]} {Dmel: FBgn0037546, mAChR-B, muscarinic Acetylcholine Receptor, B-type, [RH, Score=233, Expect=3e-64]} {Celegans: WBGene00001518, gar-2, Probable muscarinic acetylcholine receptor gar-2, [RH, Score=189, Expect=1e-54]} {Smed: dd_Smed_v6_13962_0_1, dd_Smed_v6_13962_0_1, [RH, Score=317, Expect=3e-97]} {RNA1310_44335} {RNA815_48112} |
17. | MligTC455_34892 | 372 | 7.75 | Mlig455_064967 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.604 Region-enriched R8: 3.123/0.00904 |
CYP2J2 | 0.954 | - | - | - | - | - | 0.954 | Mlig455_064967 {REF} {Length: 3245} {Pfam: Cytochrome P450 [PF00067.24, score=299.4]} {Human: ENSG00000134716, CYP2J2, cytochrome P450 family 2 subfamily J member 2, [Score=261, Expect=7e-81]} {Mouse: ENSMUSG00000052914, Cyp2j6, cytochrome P450, family 2, subfamily j, polypeptide 6, [RH, Score=276, Expect=9e-87]; ENSMUSG00000081362, Cyp2j7, cytochrome P450, family 2, subfamily j, polypeptide 7, [RH, Score=268, Expect=2e-83]; ENSMUSG00000066097, Cyp2j11, cytochrome P450, family 2, subfamily j, polypeptide 11, [RH, Score=267, Expect=2e-83]} {Dmel: FBgn0010383, Cyp18a1, Cytochrome P450-18a1, [Score=186, Expect=2e-52]} {Celegans: WBGene00016860, cyp-33C9, CYtochrome P450 family, [Score=226, Expect=4e-68]} {Smed: dd_Smed_v6_2351_0_2, dd_Smed_v6_2351_0_2, [Score=263, Expect=3e-82]} {RNA1509_38384, RNA1509_39728, RNA1509_51765} {RNA1310_10949.2, RNA1509_38384, RNA1509_39728, RNA1509_51765} {RNA1509_38384, RNA1509_39728, RNA1509_51765, RNA815_7159} |
18. | MligTC455_34430 | 109 | 2.26 | Mlig455_031496 | Neo: - Age: Up-Down-Down Region-enriched R7: 3.010/0.04401 |
TRPC4 | 0.951 | 0.951 | - | - | - | - | - | Mlig455_031496 {REF} {Length: 3366} {Pfam: Ion transport protein [PF00520.33, score=20.3]} {Human: ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [Score=90.5, Expect=4e-18]} {Mouse: ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [Score=88.2, Expect=2e-17]} {Dmel: FBgn0005614, trpl, transient receptor potential-like, [Score=84.3, Expect=2e-16]} {Celegans: WBGene00006614, trp-1, Transient-receptor-potential-like protein, [Score=73.6, Expect=3e-13]} {Smed: dd_Smed_v6_13048_0_2, dd_Smed_v6_13048_0_2, [Score=74.3, Expect=1e-13]} {RNA1310_14297} {RNA815_5679} |
19. | MligTC455_53509 | 51 | 1.05 | Mlig455_039905 | Neo: - Age: Up-Down-Up Region-enriched R7: 5.487/0.00010 |
KREMEN1 | 0.951 | 0.951 | - | - | - | - | - | Mlig455_039905 {REF} {Length: 4459} {Pfam: WSC domain [PF01822.21, score=601.0]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=65.1, Expect=6e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=65.1, Expect=4e-10]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=69.3, Expect=2e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=50.4, Expect=1e-05]} {RNA1509_15008} {RNA1310_9885} {RNA815_22574} |
20. | MligTC455_54034 | 260 | 5.41 | Mlig455_017202 | Neo: - Age: - Region-enriched R8: 2.476/0.02915 |
CALML3 | 0.95 | - | - | - | - | - | 0.950 | Mlig455_017202 {REF} {Length: 1789} {Pfam: EF hand [PF00036.34, score=86.0]; EF-hand domain pair [PF13499.8, score=75.1]; EF hand [PF13202.8, score=71.2]; EF-hand domain [PF13405.8, score=67.8]; EF-hand domain pair [PF13833.8, score=53.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=19.0]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=82.8, Expect=1e-20]; ENSG00000198668, CALM1, calmodulin 1, [Score=79.7, Expect=2e-19]; ENSG00000160014, CALM3, calmodulin 3, [Score=79.7, Expect=2e-19]; ENSG00000143933, CALM2, calmodulin 2, [Score=79.7, Expect=2e-19]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=81.6, Expect=3e-20]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=79.7, Expect=1e-19]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=79.7, Expect=1e-19]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=79.7, Expect=1e-19]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=77.8, Expect=6e-19]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=77.8, Expect=5e-19]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=77.8, Expect=4e-19]} {RNA1509_40737} {RNA1310_63281, RNA1509_40737} {RNA1509_40737, RNA815_19875} |